Calibrate

We're changing the way the world treats weight.

New York, United States · Founded 2020

Headquarters
New York, New York
Employees
51–200
Founded
2020
Business Model
B2C
Last Round
Series BAug 2021
Rounds
3

About

Calibrate is a digital metabolic health program combining clinician-prescribed GLP-1 medications (like Ozempic and Wegovy) with 1:1 video coaching and lifestyle interventions. The program targets sustainable weight loss, with members losing an average of 19% of body weight over three years.

Summary

Calibrate is a Healthcare company based in New York, United States, founded in 2020. Its most recent funding was a Series B round in Aug 2021. Investors include Forerunner Ventures, Threshold Ventures and Founders Fund.

Tech & App Stack

5 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series BSeries BAug 2021

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies